RTI uses cookies to offer you the best experience online. By clicking “accept” on this website, you opt in and you agree to the use of cookies. If you would like to know more about how RTI uses cookies and how to manage them please view our Privacy Policy here. You can “opt out” or change your mind by visiting: http://optout.aboutads.info/. Click “accept” to agree.
An exploratory cost-effectiveness analysis of the connected health intervention to improve care for people with dementia
A simulation analysis
Dowd, W., Cowell, A., Regan, D., Moran, K., Slevin, P., Doyle, G., & Bray, J. W. (2018). An exploratory cost-effectiveness analysis of the connected health intervention to improve care for people with dementia: A simulation analysis. Health Services and Outcomes Research Methodology.
Many people with dementia live in the community; thus, supporting informal caregivers is critical. The Connected Health (CH) intervention facilitates collection and sharing of patient data among informal caregivers and providers to identify emerging patient needs and support rapid decision-making. This study estimates the costs of care of dementia using time-driven activity based costing of an exemplar patient. Intervention costs and health utility values were derived from a feasibility study of the intervention. A Markov model produced estimates of the cost-effectiveness of the intervention under four scenarios: 1) a modest effect of the intervention on disease progression; 2) moderate effects on disease progression, and modest effects on quality of life (QOL) and cost; 3) modest effects on disease progression and QOL, and a moderate effect on cost; 4) moderate effects on disease progression and cost, with modest effects on QOL. Cost estimates of formal and informal care ranged from €3,713 to €7,614 per month. Intervention costs were €484 per month. Under scenarios 2, 3 and 4, the cost per quality-adjusted life year of the intervention falls below €45,000, the threshold below which the Health Information and Quality Authority in Ireland generally accepts interventions as cost-effective. The results suggest that the intervention would be cost-effective with limited reductions in rates of disease progression and cost of care, and with modest improvements in quality of life. Future research should consider the specific experiences of intervention patients.